Looking for API CDMO Partner? Looking for API CDMO Partner?

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Dr. Reddy's Laboratories

    Client Virtual Booth

    DR. REDDY'S LABORATORIES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    Key Products KEY PRODUCTS

    • Abiraterone Acetate

    • Apixaban

    • Atorvastatin

    • Bempedoic Acid

    • Clopidogrel

    • Clopidogrel Besylate

    • Clopidogrel Hydrochloride

    • Dapagliflozin

    • Dapagliflozin Propanediol Monohydrate

    • Eribulin

    • Levetiracetam

    • Losartan Potassium

    • Palbociclib

    • Ranolazine

    • Sacubitril-Valsartan

    • Sitagliptin Hydrochloride

    • Sitagliptin Malate

    • Sitagliptin Phosphate

    • Valsartan

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dr. Reddy 250x250
    Dr. Reddy\
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana-500 034
    Telephone
    Telephone
    +91 40 4900 2900
    Client Email
    Email
    API@drreddys.com
    Client Website
    Website
    https://api.drreddys.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dr--reddys-laboratories
    Twitter
    Twitter
    https://twitter.com/drreddys
    Contact Info
    Others

    Full View ScreenFull Screen View
    Dr Reddy's stock surges on positive trading day
    Dr Reddy's stock surges on positive trading day

    https://www.livemint.com/market/live-blog/dr-reddy-share-price-live-blog-for-15-may-2023-11684118295964.html

    LIVEMINT
    15 May 2023
    Share Share
    U.S. FDA issues observations for Dr. Reddy’s unit
    U.S. FDA issues observations for Dr. Reddy’s unit

    https://www.thehindu.com/business/us-fda-issues-observations-for-dr-reddys-unit/article66847628.ece

    THE HINDU
    13 May 2023
    Share Share
    Dr Reddy's Laboratories QoQ showing catches a cold on weak US sales
    Dr Reddy's Laboratories QoQ showing catches a cold on weak US sales

    https://www.business-standard.com/companies/news/weak-us-sales-weighs-on-dr-reddy-s-sequential-performance-in-march-quarter-123051100854_1.html

    BUSINESS STANDARD
    11 May 2023
    Share Share
    Dr. Reddy’s Q4 & FY23 Financial Results
    Dr. Reddy’s Q4 & FY23 Financial Results

    https://www.businesswire.com/news/home/20230510005650/en

    BUSINESSWIRE
    10 May 2023
    Share Share
    U.S.FDA observation for Dr. Reddy’s unit
    U.S.FDA observation for Dr. Reddy’s unit

    https://www.thehindu.com/business/usfda-observation-for-dr-reddys-unit/article66816803.ece

    THEHINDU
    05 May 2023
    Share Share
    Dr Reddy's Labs launches generic injection in US
    Dr Reddy's Labs launches generic injection in US

    https://health.economictimes.indiatimes.com/news/pharma/dr-reddys-labs-launches-generic-injection-in-us/99671612

    ECONOMIC TIMES
    21 Apr 2023
    Share Share
    Dr. Reddy's Lab Announces the Launch of Treprostinil In
    Dr. Reddy's Lab Announces the Launch of Treprostinil In

    https://www.businesswire.com/news/home/20230421005221/en

    BUSINESSWIRE
    21 Apr 2023
    Share Share
    Eagle Pharma Reaches Settlement Agreement with Dr. Reddy's Laboratories Inc.
    Eagle Pharma Reaches Settlement Agreement with Dr. Reddy's Laboratories Inc.

    https://www.globenewswire.com/news-release/2023/04/05/2641508/0/en/Eagle-Pharmaceuticals-Reaches-Settlement-Agreement-with-Dr-Reddy-s-Laboratories-Inc-and-Dr-Reddy-s-Laboratories-Ltd-Related-to-BENDEKA-bendamustine-hydrochloride.html

    GLOBENEWSWIRE
    05 Apr 2023
    Share Share
    Coya announces an Agreement with Dr. Reddy’s to License biosimilar Abatacept
    Coya announces an Agreement with Dr. Reddy’s to License biosimilar Abatacept

    https://www.businesswire.com/news/home/20230317005028/en

    BUSINESSWIRE
    21 Mar 2023
    Share Share
    Dr. Reddy’s divests $33M worth of dermatology brands in India
    Dr. Reddy’s divests $33M worth of dermatology brands in India

    https://endpts.com/dr-reddys-divests-33m-worth-of-dermatology-brands-in-india/

    Tyler Patchen ENDPTS
    17 Mar 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Dr. Reddy 250x250

    CPhI China 2023

    Booth # N3D99

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search